Beta-cell death is an important pathogenic element in diabetes. Our data demonstrate that endoplasmic reticulum (ER) stress contributes to beta-cell death in patients with diabetes. ER stress is caused by imbalance between the demand placed on the ER by the load of client proteins and the ability of the ER to meet that demand. The """"""""unfolded protein response"""""""" (UPR) is an adaptive response that counteracts ER stress. ER-associated protein degradation (ERAD), a component of the UPR, contributes to the survival of ER-stressed cells. Inositol Requiring 1 (IRE1) is a central regulator of the UPR. Our data show not only that IRE1 has an important function in insulin biosynthesis, but that a heavy load of client protein, insulin, causes a high baseline level of ER stress in beta-cells. This means that only a slight additional increase in ER stress is likely to lead to beta-cell death. Such an example is Wolfram syndrome (WFS). The pathogenesis of WFS, a rare form of juvenile diabetes, has been attributed to mutations in the WFS1 gene. Most of those mutations occur in exon 8, which encodes the protein's transmembrane and C-terminal luminal domains. We hypothesize that mutations in WFS1 lead to misfolding of protein in the ER, cause an increase in ER stress, and consequently lead to beta-cell death.
In Aim 1, we will examine the roles of ERAD in beta-cell death in WFS.
In Aim 2, we will determine the function of IRE1 signaling in beta-cells.
In Aim 3, we will study the molecular mechanisms of ER stress-mediated beta-cell death. The proposed studies will elucidate the relationship between ER stress and diabetes. Understanding this relationship will move us closer to our ultimate goal of developing drugs that block ER stress-mediated beta-cell death.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK067493-04S1
Application #
7879091
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Haft, Carol R
Project Start
2005-08-01
Project End
2009-12-31
Budget Start
2009-06-23
Budget End
2009-12-31
Support Year
4
Fiscal Year
2009
Total Cost
$19,024
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Genetics
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Mollereau, B; Rzechorzek, N M; Roussel, B D et al. (2016) Adaptive preconditioning in neurological diseases - therapeutic insights from proteostatic perturbations. Brain Res 1648:603-616
Urano, Fumihiko (2016) Wolfram Syndrome: Diagnosis, Management, and Treatment. Curr Diab Rep 16:6
Kim, Yeawon; Lee, Heedoo; Manson, Scott R et al. (2016) Mesencephalic Astrocyte-Derived Neurotrophic Factor as a Urine Biomarker for Endoplasmic Reticulum Stress-Related Kidney Diseases. J Am Soc Nephrol 27:2974-2982
Kanekura, Kohsuke; Ma, Xiucui; Murphy, John T et al. (2015) IRE1 prevents endoplasmic reticulum membrane permeabilization and cell death under pathological conditions. Sci Signal 8:ra62
Kanekura, Kohsuke; Ou, Jianhong; Hara, Takashi et al. (2015) Research resource: Monitoring endoplasmic reticulum membrane integrity in ?-cells at the single-cell level. Mol Endocrinol 29:473-80
Lu, Simin; Kanekura, Kohsuke; Hara, Takashi et al. (2014) A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome. Proc Natl Acad Sci U S A 111:E5292-301
Unanue, Emil R; Urano, Fumihiko (2014) Endoplasmic reticulum: an interface between the immune system and metabolism. Diabetes 63:48-9
Hara, Takashi; Mahadevan, Jana; Kanekura, Kohsuke et al. (2014) Calcium efflux from the endoplasmic reticulum leads to ?-cell death. Endocrinology 155:758-68
Urano, Fumihiko (2014) Diabetes: Targeting endoplasmic reticulum to combat juvenile diabetes. Nat Rev Endocrinol 10:129-30
Urano, Fumihiko (2014) Wolfram syndrome iPS cells: the first human cell model of endoplasmic reticulum disease. Diabetes 63:844-6

Showing the most recent 10 out of 36 publications